Average Co-Inventor Count = 8.63
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novartis Ag (14 from 3,923 patents)
2. Glaxo Group Limited (3 from 1,168 patents)
3. Novartis Vaccines & Diagnostics, Gmbh (1 from 245 patents)
18 patents:
1. 11160797 - Pyridinone derivatives and their use as selective ALK-2 inhibitors
2. 10919887 - Salts and solid forms of a monobactam antibiotic
3. 10660888 - Aminoheteroaryl benzamides as kinase inhibitors
4. 10369138 - Monobactam organic compounds for the treatment of bacterial infections
5. 10188649 - Aminoheteroaryl benzamides as kinase inhibitors
6. 9763937 - Aminoheteroaryl benzamides as kinase inhibitors
7. 9546173 - Substituted pyrrolo[3,4-d]pyrimidines as kinase inhibitors
8. 9242996 - Aminoheteroaryl benzamides as kinase inhibitors
9. 9174978 - Monobactam organic compounds for the treatment of bacterial infections
10. 8829193 - PIM kinase inhibitors and methods of their use
11. 8822497 - PIM kinase inhibitors and methods of their use
12. 8735424 - Bicyclic kinase inhibitors
13. 8710048 - 6-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signaling
14. 8168794 - Pim kinase inhibitors and methods of their use
15. 7709497 - Pyrazolo[3,4-b]pyridine compound, and its use as a PDE4 inhibitor